|
The ASCO Cancer Foundation® International Development and Education Award (IDEA) program has provided 20 non-U.S. oncologists with the opportunity to travel to the 2009 ASCO Annual Meeting. Designed to improve global oncology care by providing support to early-career oncologists practicing in countries with limited resources, the program provides a monetary award that covers expenses associated with attending the Meeting. It includes complimentary Meeting registration and admission to a limited number of ticketed Meeting sessions. Eligible recipients also receive 3 years of complimentary ASCO membership, which includes a subscription to the Journal of Clinical Oncology (JCO).
The program allows participants who practice or conduct research outside of the United States to expand their current knowledge, earn continuing medical education (CME) credits, and share their learning experiences from the Meeting with colleagues in their home countries. Since its inception in 2002, the program has enabled 140 oncologists — representing 40 countries — to participate in the Meeting.
Award recipients are paired with a mentor from a team of volunteer ASCO leaders. Mentors help enhance the Meeting experience for recipients and provide advice about career development. After the Meeting has ended, each recipient is given the opportunity to spend several days visiting his or her mentor’s institution. This educational experience allows recipients to share new insights and research results with their colleagues and to facilitate changes and improvements to the practices and research infrastructures in their home countries.
New this year, recipients will participate in a special training session as part of the American Cancer Society University Program. Recipients will learn strategies for mobilizing patients for advocacy, working with non-government programs, and understanding cancer planning at a country level. Recipients also will participate in a workshop on dissemination strategies to learn techniques for becoming agents of change in their local oncology communities. Clement Adebamowo, MD, Chair of the IDEA Working Group and a past IDEA recipient, will lead this collaborative discussion.
The 2009 IDEA Program is supported through The ASCO Cancer Foundation, Roche, Millenium Pharmaceuticals, Inc., Merck Serono, and Amgen. Strongest consideration for the awards was given to candidates who submitted an abstract for the 2009 Annual Meeting. Recipients were restricted to having fewer than 10 years of experience in the field of oncology and to a maximum of 1 year of “formal training” in the United States, Canada, Western Europe, Australia, or New Zealand. Candidates also were restricted to having attended no more than one previous ASCO Annual Meeting.
The application period for the 2010 IDEA Program will open in October 2009. Questions can be submitted by sending an e-mail to idea@asco.org.
The 2009 ASCO Cancer Foundation® IDEA Recipients
IDEA recipients who will present their research during the 2009 ASCO Annual Meeting are indicated with an asterisk. Session information, including location and time, is listed below.
Raafat Abdel Malek, MBBCh, FRCR
Cairo University
Cairo, Egypt
Dauren Adilbay, MD
N.N. Blokhin Russian Cancer Research Center
Almaty, Kazakhstan
Leticia Arruda, MD
ONCOVIDA – Instituto Especializado de Oncologia Clínica
Brasília, Brazil
Hua-Jun Chen, MD, PhD
Guangdong Lung Cancer Institute, Guangdong General Hospital
Guangzhou, China
Timucin Cil, MD
Dicle University Hospital
Diyarbakir, Turkey
*Cynthia Villarreal-Garza, MD
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico
“Knowledge about cancer screening among medical students and residents” (Abstract 1541)
General Poster Session, Cancer Prevention: Cancer Prevention/Epidemiology
Sunday, May 31, 2009
2:00 PM-6:00 PM, West Hall C
Bijesh Ghimire, MD, MBBS
Om Hospital and Research Centre
Kathmandu, Nepal
Kashif Iqbal, MBBS, MS
Nuclear Medicine, Oncology and Radiotherapy Institute
Islamabad, Pakistan
Parisa Karimi, MD
Immunology, Asthma & Allergy Research Institute
Tehran, Iran
Andréia Melo, MD
Brazilian National Cancer Institute
Rio de Janeiro, Brazil
Ilham Merad-Lahfa, MD
Hospitalo-University Center of Tlemcen
Tlemcen, Algeria
Susan Msadabwe, MBCHB, FC Rad Onc
Cancer Diseases Hospital
Lusaka, Zambia
Catherine Naliaka Nyongesa, MD, MBchB(Nbi), MMED Rad Onc, FC Rad Onc
Kenyatta National Hospital
Nairobi, Kenya
Ritwik Pandey, MBBS, MD, DM
Netaji Subhash Chandra Bose Cancer Research Institute
Kolkata, India
Naiyarat Prasongsook, MD
Phramongkutklao Hospital
Bangkok, Thailand
Roxana Ioana Scheusan, MD
City Hospital Timisoara
Timisoara, Romania
Roman Shyyan, MD, MSc
Lviv Regional Cancer Center
Lviv, Ukraine
Luis Ubillos, MD
Instituto Nacional del Cáncer
Montevideo, Uruguay
Tabassum Wadasadawala, MD, DNB
Tata Memorial Hospital
Mumbai, India
Yang Xu, MD, PhD
Liver Cancer Institute
Shanghai, China
|
